Why are WHO talks on novel tobacco products postponed from COP9 to 2023?

The World Health Organization (WHO) has decided to postpone a discussion on novel tobacco products to a face-to-face event in 2023 – a decision experts are linking to a lack of consensus on what approach to take to tobacco alternatives.

Organisers of the ninth Conference of the Parties (COP9) to the WHO Framework Convention on Tobacco Control (WHO FCTC), which will take place online in November, blames the postponement on “the limited time available for the virtual session and the substantive discussions expected”.

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization